Northwest Biotherapeutics Inc
NWBO
Market Cap$345.99M
Close$
$-0.12
153.9% downside
Current Fair Value
153.9% downsideOvervalued by 153.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $345.99 Million |
|---|---|
| Enterprise Value | $412.22 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.07 |
| Beta | -1.09 |
| Outstanding Shares | 1,359,496,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.84 |
|---|---|
| PEG | -54.19 |
| Price to Sales | - |
| Price to Book Ratio | -0.23 |
| Enterprise Value to Revenue | 279.85 |
| Enterprise Value to EBIT | -5.47 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | -0.81 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Northwest Biotherapeutics Inc
CEO: Linda Powers